Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1639 1644 1675 1682 1684
This examiner grants 77% of resolved cases
Kaijiang Zhang is an examiner in Tech Center 1600 and Art Unit 1612. He has 704 resolved cases. The allowance rate for these cases is 77.1%. This percentage is a metric for practitioners to consider during prosecution. The interview lift is 34.4%. This lift shows the change in allowance probability when an interview occurs. The median days to allowance is 990. This duration is the time for an allowed application.
With 704 resolved cases, the data provides a basis for strategy. The 34.4% interview lift is a metric for those seeking to change their results. Practitioners should factor the 990-day timeline into their planning. The 77.1% allowance rate reflects the examiner's record in Tech Center 1600 and Art Unit 1612. The examiner's history shows a pattern of outcomes. Direct communication through the interview process is associated with the lift. The Art Unit environment is associated with these metrics. The duration of prosecution is a factor in strategy. The Tech Center context is relevant for understanding the trends.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18323091 | METHODS FOR PRINTING CELLS AND GENERATING ARRAYS OF BARCODED CELLS | Non-Final OA | 10x Genomics, Inc. |
| 17820560 | METHODS FOR PROCESSING NUCLEIC ACID MOLECULES | Final Rejection | 10x Genomics, Inc. |
| 17963119 | MULTI-SEQUENCE CAPTURE SYSTEM | Non-Final OA | University of Utah Research Foundation |
| 18130306 | MICROFLUIDIC ACOUSTIC SEPARATION DEVICES | Non-Final OA | The Charles Stark Draper Laboratory, Inc. |
| 17856923 | CHEMICAL METHODS FOR PRODUCING TAGGED NUCLEOTIDES | Non-Final OA | ROCHE SEQUENCING SOLUTIONS, INC. |
| 17924425 | POLYNUCLEOTIDE ARRAYS | Final Rejection | Oxford University Innovation Limited |
| 17464341 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Non-Final OA | Fred Hutchinson Cancer Center |
| 17412105 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Non-Final OA | Fred Hutchinson Cancer Center |
| 17978130 | SEQUENCING KITS | Non-Final OA | ILLUMINA, INC. |
| 17751017 | Sequencing Adapter Manufacture and Use | Non-Final OA | Sequenom, Inc. |
| 18298043 | ENRICHMENT OF MUTATED CELL FREE NUCLEIC ACIDS FOR CANCER DETECTION | Non-Final OA | GRAIL, LLC |
| 17853846 | METHODS FOR ENRICHING FOR DUPLEX READS IN SEQUENCING AND ERROR CORRECTION | Non-Final OA | GRAIL, LLC |
| 18067652 | DE NOVO SYNTHESIZED GENE LIBRARIES | Non-Final OA | Twist Bioscience Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy